Följ
Mark Frydenberg
Mark Frydenberg
Professor, Department of Surgery, Monash University
Verifierad e-postadress på monash.edu
Titel
Citeras av
Citeras av
År
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised …
MS Hofman, N Lawrentschuk, RJ Francis, C Tang, I Vela, P Thomas, ...
The Lancet 395 (10231), 1208-1216, 2020
13032020
Enzalutamide with standard first-line therapy in metastatic prostate cancer
ID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ...
New England Journal of Medicine 381 (2), 121-131, 2019
11762019
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...
European urology 73 (2), 178-211, 2018
837*2018
Phytoestrogens
AL Murkies, G Wilcox, SR Davis
The Journal of Clinical Endocrinology & Metabolism 83 (2), 297-303, 1998
8251998
Laparoscopic and robotic‐assisted versus open radical prostatectomy for the treatment of localised prostate cancer
D Ilic, SM Evans, CA Allan, JH Jung, D Murphy, M Frydenberg
Cochrane Database of Systematic Reviews, 2017
2852017
Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy?
JP Grummet, M Weerakoon, S Huang, N Lawrentschuk, M Frydenberg, ...
BJU international 114 (3), 384-388, 2014
2622014
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer
MJ Watt, AK Clark, LA Selth, VR Haynes, N Lister, R Rebello, LH Porter, ...
Science translational medicine 11 (478), eaau5758, 2019
2572019
Defining a standard set of patient-centered outcomes for men with localized prostate cancer
NE Martin, L Massey, C Stowell, C Bangma, A Briganti, A Bill-Axelson, ...
European urology 67 (3), 460-467, 2015
2402015
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
A Kneebone, C Fraser-Browne, GM Duchesne, R Fisher, M Frydenberg, ...
The Lancet Oncology 21 (10), 1331-1340, 2020
2292020
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories
RA Taylor, M Fraser, J Livingstone, SMG Espiritu, H Thorne, V Huang, ...
Nature communications 8 (1), 13671, 2017
2252017
Local aromatase expression in human prostate is altered in malignancy
SJ Ellem, JF Schmitt, JS Pedersen, M Frydenberg, GP Risbridger
The Journal of Clinical Endocrinology & Metabolism 89 (5), 2434-2441, 2004
2162004
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 …
GM Duchesne, HH Woo, JK Bassett, SJ Bowe, C D'Este, M Frydenberg, ...
The Lancet Oncology 17 (6), 727-737, 2016
2122016
Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men
RI McLachlan, L O’Donnell, PG Stanton, G Balourdos, M Frydenberg, ...
The Journal of Clinical Endocrinology & Metabolism 87 (2), 546-556, 2002
2122002
The role of magnetic resonance imaging in the diagnosis and management of prostate cancer
J Thompson, N Lawrentschuk, M Frydenberg, L Thompson, P Stricker, ...
BJU international 112, 6-20, 2013
1932013
Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer
FS Dalais, A Meliala, N Wattanapenpaiboon, M Frydenberg, DAI Suter, ...
Urology 64 (3), 510-515, 2004
1872004
Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones
RA Jarred, M Keikha, C Dowling, SJ McPherson, AM Clare, AJ Husband, ...
Cancer Epidemiology Biomarkers & Prevention 11 (12), 1689-1696, 2002
1862002
Active surveillance for prostate cancer: a narrative review of clinical guidelines
SM Bruinsma, CH Bangma, PR Carroll, MS Leapman, A Rannikko, ...
Nature Reviews Urology 13 (3), 151-167, 2016
1742016
EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU …
JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ...
European urology 77 (2), 223-250, 2020
1642020
Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice
E Salminen, A Hogg, D Binns, M Frydenberg, R Hicks
Acta Oncologica 41 (5), 425-429, 2002
1532002
Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor …
GP Risbridger, RA Taylor, D Clouston, A Sliwinski, H Thorne, S Hunter, ...
European Urology 67 (3), 496-503, 2015
1462015
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20